ScholarIQanswers from OpenAlex

Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis

PaperCitations, authors & open-access status

Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis have?

ScholarIQcitation count

Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis has 65 citations in the OpenAlex counts ScholarIQ stores.

When was Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis published?

ScholarIQyear

Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis has 1997 year in the ScholarIQ index.

What is the open-access status of Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis?

ScholarIQoa status

Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis has green oa status in the ScholarIQ index.

What is the DOI of Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis?

ScholarIQdoi

The DOI for Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis is on the source record.

What is the PMID of Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis?

ScholarIQpmid

The PMID for Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis is on the source record.

What is the OpenAlex record for Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis?

ScholarIQopenalex

The OpenAlex for Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial